ConductScience.org, home

Paper37012015

Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial).

Zoungas S and 17 others. BMJ Open, 2023. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial). Papers, record 37012015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37012015

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial).
PubMed
Journal
BMJ Open
PubMed
Year
2023
PubMed
Publication types
Clinical Trial Protocol, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
6.52
iCite
Revised in PubMed
2023-04-12
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zoungas SSophiahttps://orcid.org/0000-0003-2672-0949
2Curtis AAndrea
3Spark SSimone
4Wolfe RRoryhttps://orcid.org/0000-0002-2126-1045
5McNeil JJJohn J
6Beilin LLawrence
7Chong TTTrevor T-J
8Cloud GGeoffrey
9Hopper IIngrid
10Kost AAlissia
11Nelson MMark
12Nicholls SJStephen J
13Reid CMChristopher M
14Ryan JJoannehttps://orcid.org/0000-0002-7039-6325
15Tonkin AAndrew
16Ward SAStephanie A
17Wierzbicki AAnthony
18STAREE investigator groupGroup

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hydroxymethylglutaryl-CoA Reductase InhibitorsMajor topic
Cardiovascular DiseasesMajor topic
Myocardial InfarctionMajor topic
StrokeMajor topic
DementiaMajor topic
Aged
Humans
Aged, 80 and over
Quality of Life
Australia
Primary Prevention
Primary Health Care
Randomized Controlled Trials as Topic

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02099123A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)Derived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115673344Relationship between plasma lipids and all-cause mortality in nondemented elderly.J Am Geriatr Soc2005https://conductscience.org/library/papers/15673344PubMed
231752701Disability incidence and functional decline among older adults with major chronic diseases.BMC Geriatr2019https://conductscience.org/library/papers/31752701PubMed
316291918Epidemiology and risk factors of dementia.J Neurol Neurosurg Psychiatry2005https://conductscience.org/library/papers/16291918PubMed
423529608Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials.Eur J Prev Cardiol2013https://conductscience.org/library/papers/23529608PubMed
524866986Statins in the elderly: an answered question?Curr Opin Cardiol2014https://conductscience.org/library/papers/24866986PubMed
628385949Primary Prevention With Statin Therapy in the Elderly: New Meta-Analyses From the Contemporary JUPITER and HOPE-3 Randomized Trials.Circulation2017https://conductscience.org/library/papers/28385949PubMed
715803163Statins--a cure-all for the brain?Nat Rev Neurosci2005https://conductscience.org/library/papers/15803163PubMed
811559371The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol.J Am Geriatr Soc2001https://conductscience.org/library/papers/11559371PubMed
928168689Effect of Physical Activity on Self-Reported Disability in Older Adults: Results from the LIFE Study.J Am Geriatr Soc2017https://conductscience.org/library/papers/28168689PubMed
1030586759Quantifying Importance of Major Risk Factors for Coronary Heart Disease.Circulation2019https://conductscience.org/library/papers/30586759PubMed
1132616158Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults.J Am Coll Cardiol2020https://conductscience.org/library/papers/32616158PubMed
1219801098Ageing populations: the challenges ahead.Lancet2009https://conductscience.org/library/papers/19801098PubMed
1330221597Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.N Engl J Med2018https://conductscience.org/library/papers/30221597PubMed
1430003171Impact of informed consent content and length on recruitment of older adults into a community based primary prevention trial.Contemp Clin Trials Commun2018https://conductscience.org/library/papers/30003171PubMed
1519770150Human population growth and the demographic transition.Philos Trans R Soc Lond B Biol Sci2009https://conductscience.org/library/papers/19770150PubMed
1618061058Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.Lancet2007https://conductscience.org/library/papers/18061058PubMed
1727838724Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence.JAMA2016https://conductscience.org/library/papers/27838724PubMed
1818449611Prevalence of musculoskeletal pain and statin use.J Gen Intern Med2008https://conductscience.org/library/papers/18449611PubMed
1925313241Prevalence of frailty and disability: findings from the English Longitudinal Study of Ageing.Age Ageing2015https://conductscience.org/library/papers/25313241PubMed
2030355005Updated Criteria for Population-Based Stroke and Transient Ischemic Attack Incidence Studies for the 21st Century.Stroke2018https://conductscience.org/library/papers/30355005PubMed

See all 52 referencesDownload CSV of references

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
42825089Association between timing of statin treatment after diabetes diagnosis and risk of dementia: a nationwide observational study.Lancet Reg Health Eur2026https://conductscience.org/library/papers/42825089PubMed
42818935Multi-trait Polygenic Profiling and Survival Free of Dementia and Disability: Results from the Health and Retirement Study.medRxiv2026https://conductscience.org/library/papers/42818935PubMed
42728062Deprescribing statins for adults 65 years of age and older: Evidence-based clinical practice guideline.Can Fam Physician2026https://conductscience.org/library/papers/42728062PubMed
42461299[Austrian lipid consensus : Interdisciplinary evidence-based recommendations on prevention and treatment of lipid-associated diseases from 15 medical specialist societies].Wien Klin Wochenschr2026https://conductscience.org/library/papers/42461299PubMed
42396578LDL-cholesterol distance to target: A practical tool for guiding lipid-lowering treatment decisions.Atheroscler Plus2026https://conductscience.org/library/papers/42396578PubMed
42340940Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study.PLoS Med2026https://conductscience.org/library/papers/42340940PubMed
42291043Statin use and cognitive outcomes in older adults.Am J Prev Cardiol2026https://conductscience.org/library/papers/42291043PubMed
42203295Pragmatic trial assessing polygenic risk driven statin therapy for cardiovascular disease prevention: study protocol for the EE-PRS trial.BMJ Open2026https://conductscience.org/library/papers/42203295PubMed
42100682Lipid-lowering therapy for primary prevention of cardiovascular disease in adults aged 75 years and older: a narrative review.Int J Cardiol Cardiovasc Risk Prev2026https://conductscience.org/library/papers/42100682PubMed
41732846Ezetimibe alone for over 75 years old as a primary prevention to decrease cardiovascular events.Ann Med2026https://conductscience.org/library/papers/41732846PubMed
41718130Efficacy and Safety of Statins in MASLD and Other Chronic Liver Diseases.Med Sci (Basel)2026https://conductscience.org/library/papers/41718130PubMed
41645316Investigating estimand considerations in adaptive trials: a systematic review.Trials2026https://conductscience.org/library/papers/41645316PubMed
41478887Optimizing cardiovascular pharmacotherapy in older adults with frailty.Nat Rev Cardiol2026https://conductscience.org/library/papers/41478887PubMed
41400788Lipid-Lowering Therapies and Cognition in Older Adults: A Narrative Review and Clinical Considerations.Curr Cardiol Rep2025https://conductscience.org/library/papers/41400788PubMed
40924377Cardiovascular Risk Prediction in Older Adults.Curr Atheroscler Rep2025https://conductscience.org/library/papers/40924377PubMed
40869565Statin Treatment for Reducing Mortality Risk in Individuals over 75 Years of Age: A Large-Scale Retrospective Analysis.J Clin Med2025https://conductscience.org/library/papers/40869565PubMed
40801072In the wake of the Scandinavian Simvastatin Survival Study trial.Curr Opin Lipidol2025https://conductscience.org/library/papers/40801072PubMed
40409969Rationale and design of 'discontinuing statins in multimorbid older adults without cardiovascular disease (STREAM)': study protocol of a randomised non-inferiority clinical trial.BMJ Open2025https://conductscience.org/library/papers/40409969PubMed
40338434Lipid-Lowering Therapy and Cardiovascular Prevention in Elderly.Drugs2025https://conductscience.org/library/papers/40338434PubMed
40294956SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials.BMJ2025https://conductscience.org/library/papers/40294956PubMed

See all 45 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
HMGCR3156PubTator's text mininghttps://conductscience.org/library/genes/3156NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
ATORVASTATINCHEMBL1487Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1487

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37012015

GET https://conductscience.org/api/papers/v1/37012015/references?page=2